allergy banner

Videos


Open Access Agreements with Wiley



Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Free access

Articles


IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis

Maintz, L., Welchowski, T., Herrmann, N., et al. Allergy. First published: 17 January 2023

Fatal and near-fatal anaphylaxis: the Allergy-Vigilance® Network data (2002-2020)

Pouessel, G., Alonzo, S., Divaret-Chauveau, A., Dumond, P., et al. Allergy. First published: 16 January 2023

Detergent-induced eosinophilic inflammation in the esophagus: A key evidence for the Epithelial Barrier Theory

Yazici, D., Pat, Y., Mitamura, Y., Akdis, C.A. and Ogulur, I. Allergy. First published: 16 January 2023

The Molecular Allergology User's Guide version 2.0 is freely available!

Hoffmann-Sommergruber, K., Santos, A.F. and Breiteneder, H. Allergy. First published: 12 January 2023

Early infancy dysbiosis in food protein-induced enterocolitis syndrome: a prospective cohort study

Su, K.-W., Cetinbas, M., Martin, V.M., et al. Allergy. First published: 12 January 2023

Severe cutaneous adverse reactions after covid-19 vaccination: A systematic review

Wu, P.-C., Huang, I.-H., Wang, C.-W., Chung, W.-H. and Chen, C.-B. Allergy. First published: 10 January 2023

Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction

Kim, J., Kim, B.E., Berdyshev, E., et al. Allergy. First published: 07 January 2023

Berotralstat for the prophylaxis of hereditary angioedema – Real world evidence data from the United Kingdom

Ahuja, M., Dorr, A., Bode, E., et al. Allergy. First published: 07 January 2023

Angiomotin and angiostatin as asthma biomarkers: implications for the regulation of airway remodeling and inflammation

Lee, P.-H., Choi, S., An, M., et al. Allergy. First published: 05 January 2023

Overall and respiratory mortality reduction with physical activity in subjects with and without asthma

Lee, H., Ryu, J., Chung, S.J., et al. Allergy. First published: 05 January 2023

Association of fracture incidence in children with the development of food allergy: A Korean nationwide birth cohort study

Kwon, R., Shin, Y.H., Shin, J.I., et al. Allergy. First published: 05 January 2023

Autologous Th2-polarized lymphocytes induce atopic dermatitis lesions in non-atopic human skin xenotransplants

Keren, A., Reich, K., Bertolini, M., et al. Allergy. First published: 04 January 2023

Respiratory virome profiles reflect antiviral immune responses

Rubió, J.R., Megremis, S., Pasioti, M., et al. Allergy. First published: 03 January 2023

How does particulate air pollution affect barrier functions and inflammatory activity of lung vascular endothelium?

Olesiejuk, K. and Chałubiński, M. Allergy. First published: 01 January 2023

An artificial intelligence algorithm-based smartphone application for daily cough monitoring

Shim, J.-S., Kim, M.-H., Lee, S.M., et al. Allergy. First published: 01 January 2023

A compilation answering 50 questions on Monkeypox virus and the current Monkeypox outbreak

Cabanillas, B., Murdaca, G., Guemari, A., et al. Allergy. First published: 01 January 2023

Importance of examining atopic dermatitis disease mechanisms in African populations

Lunjani, N., Akdis, C.A. and O'Mahony, L. Allergy. First published: 28 December 2022

Introduction of General Chapters on standard methods for allergen quantification in the European Pharmacopoeia

Zimmer, J., Bonertz, A., Kaul, S. and Vieths, S. Allergy. First published: 28 December 2022

IL-5 receptor expression in lung fibroblasts: potential role in airway remodeling in asthma

Bajbouj, K., AbuJabal, R., Sahnoon, L., et al. Allergy. First published: 27 December 2022

Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicals

Mota, D., Rama, T.A. and Moreira, A. Allergy. First published: 26 December 2022

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022

Oral immunotherapy for food allergy: what's age got to do with it?

Upton, J.E.M., Correa, N. and Eiwegger, T. Allergy. First published: 20 December 2022

Deciphering the role of platelets in severe allergy by an integrative omics approach

Pablo-Torres, C., Izquierdo, E., Tan, T.J., et al. Allergy. First published: 17 December 2022

Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit

Dorr, A.D., Chopra, C., Coulter, T.I., et al. Allergy. First published: 12 December 2022

Reduced intra-subject variability of an automated skin prick test device compared to a manual test

Gorris, S., Uyttebroek, S., Backaert, W., et al. Allergy. First published: 10 December 2022

Different phenotypes of drug-induced anaphylaxis - data from the European Anaphylaxis Registry

Hanschmann, T., Francuzik, W., Dölle-Bierke, S., et al. Allergy. First published: 08 December 2022

Medical algorithm: Diagnosis and management of histaminergic angioedema

Ferrer, M., Rodriguez-Garijo, N. and Sabaté-Brescó, M. Allergy. First published: 08 December 2022

Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study

Céspedes, J.A., Fernández-Santamaría, R., Ariza, A., et al. Allergy. First published: 07 December 2022

PKCα interacts with Cav1.3 calcium channels to promote the Cav1.2/Cav1.3 duo tuning Th2 functions

Giang, N., Villeneuve, T., Maire, K., et al. Allergy. First published: 07 December 2022

Atopic dermatitis: The importance of future research in Africa

Fehr, D., Lang, C., Masenga, J., et al. Allergy. First published: 05 December 2022

Intravenous immunoglobulins, cyclosporine and best supportive care in Epidermal Necrolysis: Diverse effects on systemic inflammation

Schmidt, V., Lalevée, S., Traidl, S., et al. Allergy. First published: 04 December 2022

Sounding the alarmins – the role of alarmin cytokines in asthma

Gauvreau, G.M., Bergeron, C., Boulet, L.-P., et al. Allergy. First published: 04 December 2022

Loss of PP4 contributes to DEP-induced epithelial barrier integrity disruption and alarmins release

Yang, F.-M., Hu, M.-C., Weng, C.-M., et al. Allergy. First published: 05 December 2022

Systemic gene signature of inhaled corticosteroid treatment in allergic asthma to flour

Ndika, J., Suojalehto, H., Lindström, I., et al. Allergy. First published: 01 December 2022

Early-life fecal metabolomics of food allergy

Lee-Sarwar, K.A., Chen, Y.-C., Lasky-Su, J., et al. Allergy. First published: 30 November 2022

Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances

Kaplan, A., Lebwohl, M., Giménez-Arnau, A.M., et al. Allergy. First published: 30 November 2022

IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases

Aranda, C.J., Gonzalez-Kozlova, E., Saunders, S.P., et al. Allergy. First published: 29 November 2022

COVID-19 pandemic and environment: Not only air pollution

Caminati, M., Guarnieri, G., Marchetti, P., et al. Allergy. First published: 28 November 2022

Basophil reactivity to BNT162b2 in COVID-19 convalescence

Perkins, G.B., Hurtado, P.R. and Hissaria, P. Allergy. First published: 28 November 2022

Reply to: “COVID-19 pandemic and environment: Not only air pollution.”

Fiorito, S., Soligo, M., Gao, Y., Ogulur, I., Akdis, C.A. and Bonini, S. Allergy. First published: 28 November 2022

Depletion of Mcpt8-expressing cells reduces lung mast cells in mice with experimental asthma

Alvarado-Vazquez, P.A., Cardenas, E.I., Das, A. and Hallgren, J. Allergy. First published: 27 November 2022

Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses

Logan, K., Bahnson, H.T., Ylescupidez, A., et al. Allergy. First published: 27 November 2022

Prepregnancy body mass index and risk of childhood asthma

Rosenquist, N.A., Richards, M., Ferber, J.R., et al. Allergy. First published: 27 November 2022

Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients

Spekhorst, L.S., van de Rijst, L.P., de Graaf, M., et al. Allergy. First published: 24 November 2022

Fenebrutinib and BTK inhibition: unveiling a new target for the treatment of chronic spontaneous urticaria

Carvallo, A., Sánchez-Fernández, S. and Morales-Palacios, M.P. Allergy. First published: 24 November 2022

Recent developments in the immunopathology of COVID-19

Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022

Bet v 1-independent sensitization to major allergens in Fagales pollen: evidence at the T cell level

Polak, D., Vollmann, U., Grilo, J., et al. Allergy. First published: 24 November 2022

Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling

Bitting, K., Hedgespeth, B., Ehrhardt-Humbert, L.C., et al. Allergy. First published: 24 November 2022

GALTectomy increases the risk of allergic rhinitis: A nationwide population-based cohort study

Lin, T.-M., Hsu, H.-C., Shen, Y.-C., et al. Allergy. First published: 22 November 2022

Nutritional metabolites as biomarker for food intake to improve dietary-based randomized control trials

Venter, C. and Frei, R. Allergy. First published: 22 November 2022

Pest sensitization to cockroach, mouse, and rat: an Italian multicenter study

Liccardi, G., Maria Beatrice, B., Calzetta, L., et al. Allergy. First published: 18 November 2022

Frequent presence of major dust mite allergens in human digestive tissues of children with gastritis

Zhou, Y., Yang, S., Lin, Q., He, Q. and Cui, Y. Allergy. First published: 18 November 2022

RAB25 coordinates filaggrin-containing keratohyalin granule maturation and affects atopic dermatitis severity

Jeong, H., Lee, N., Uhm, C., et al. Allergy. First published: 16 November 2022

Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience

Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes KITD816V in blood of mastocytosis and MCAS

Navarro-Navarro, P., Alvarez-Twose, I., Pérez-Pons, A., et al. Allergy. First published: 16 November 2022

Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria

Terhorst-Molawi, D., Hawro, T., Grekowitz, E., et al. Allergy. First published: 16 November 2022

Precision cut intestinal slices, a novel model of acute food allergic reactions

Hung, L., Celik, A., Yin, X., et al. Allergy. First published: 14 November 2022

Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: a systematic review

Broderick, C., Ziehfreund, S., van Bart, K., et al. Allergy. First published: 10 November 2022

Citations: 86

The role of peripheral blood eosinophil counts in COVID-19 patients

Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482

Citations: 66

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766

Citations: 66

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639

Citations: 66

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676

Citations: 64

ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – An EAACI-ARIA Position Paper

Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres, M.J., et al. Allergy. 2021; 76: 1624-1628

Citations: 58

Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?

Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618

Citations: 53

Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation

Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. 2021; 76: 3307-3313

Citations: 41

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, Cardona, V, DunnGalvin, A, Garvey, L, H, et al et al. Allergy. 2022; 2022; 77: 357– 377

Citations: 41

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., et al. Allergy. 2021; 76: 1640-1660

Citations: 38

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G., et al. Allergy. 2021; 76: 1765-1775

Citations: 35

Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!

Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., Phillips, E.J., Stone, C.A., Jr and Garvey, L.H. Allergy. 2021; 76: 2916-2920

Citations: 35

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353

Citations: 34

In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion

Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. 2022; 77: 111– 117

Citations: 33

Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice

Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432

Citations: 32

Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19

Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L., et al. Allergy. 2021; 76: 2866-2881

Citations: 32

Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

Torres, MJ, Trautmann, A, Böhm, I, Scherer, K, Barbaud, A, Bavbek, S, et al. Allergy. 2021; 76: 1325– 1339

Citations: 31

The role of allergen-specific IgE, IgG and IgA in allergic disease

Shamji, MH, Valenta, R, Jardetzky, T, Verhasselt, V, Durham, S, R, Würtzen, P, A, et al. Allergy. 2021; 76: 3627– 3641

Citations: 30

Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19

Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C., et al. Allergy. 2021; 76: 1846-1858

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

Risk factors for severe and critically ill COVID-19 patients: A review

Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455

Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Advances and recent developments in asthma in 2020

Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update

Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022

Recent developments in the immunopathology of COVID-19

Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022

Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience

Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022

Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies

Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022

Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines

Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022

Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies

Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022

Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry

Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022

The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma

Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022

Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity

Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022

Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection

Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022

T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19

Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022

Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022

COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab

Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022

Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern

Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022

Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022

Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022

Are health care policies for COVID-19 evidence-based?

Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022

Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro

Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022

Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Junior Members Corner



Dear Junior Members,



ISMA-RHINA Digital 2022

The Food Allergy and Anaphylaxis meeting (FAAM) and the European Consortium on the Application of Flow Cytometry in Allergy (EUROBAT) was held between 1-3 December 2022 in an online format. More than 600 participants joined this exciting meeting, where experts from all over the world and young scientists discussed the latest data on food allergy, anaphylaxis and the usefulness of basophil and mast cell activation tests.

EAACI Junior Members played an important role throughout the event. During EUROBAT, Leticia de las Vecillas, chair of the EAACI Junior Members Assembly (JMA), presented an interesting poster related to the usefulness of the basophil activation test in Rivaroxaban allergy. In addition, Ruben Fernandez-Santamaria, JM representative for the Basic and Clinical Immunology Section, presented an oral abstract related to the basophil activation test and chemotherapeutic agents.

Junior members also played a key role during FAAM, with posters and oral presentations related to risk factors, prevention, mechanisms, immunotherapy, and clinical management of food allergy. It is worth mentioning the presentation by Carmen Riggioni, past chair of the JMA, who explained in depth and comprehensively the EAACI guidelines on the diagnosis of food allergy.

The JM assembly would like to congratulate and thank all the participants in this meeting, especially the junior members, whose work, scientific contribution, and enthusiasm significantly improve our specialty on a daily basis.

We look forward to seeing you at the next EAACI events!


FAAM



FAAM

Best regards,
The Junior Member Assembly